Addendum...Of Interest this Week
FDA Failing to Monitor Safety of Medical Devices - The U.S. Food and Drug Administration (FDA) is not doing its job of properly monitoring the safety of medical devices, the authors of a new report charges. HealthDay News, Nov.2nd.
Genentech Offers Secret Rebates to Promote Lucentis - Genentech has begun offering secret rebates to eye doctors as an apparent inducement to get them to use more of the company’s expensive drug Lucentis rather than a less costly alternative. - New York Times, Nov 3rd.
Watchdog Says FDA Risked Integrity - Congress's watchdog arm has criticized the Food and Drug Administration for creating the appearance of favoritism toward a Boston company that won lucrative first rights to sell a generic drug after providing free consulting work to the agency. Wall Street Journal, Nov. 8th.
Stage Set for Showdown on Online Privacy - Privacy advocates are pushing for a “do not track” feature that would let Internet users tell Web sites to stop surreptitiously tracking their online habits and collecting clues about age, salary, health, location and leisure activities. New York Times, Nov. 9th.
Club Car Recalls Golf Cars and Hospitality, Utility and Transport Vehicles - The brake pedal can crack and separate, resulting in a loss of braking ability. Kansas City Info Zine, Nov. 9th.
J&J in Talks to Resolve US Probe of Risperdal Marketing - Johnson & Johnson said it's in discussions with the government to resolve a long-running investigation of whether it improperly marketed the antipsychotic Risperdal. Fox Business News, Nov.10th
